Management of multiple sclerosis in adolescents – current treatment options and related adherence issues

References

• Bar-OrAThe immunology of multiple sclerosisSemin Neurol2008281294518256985
   PubMed Web of Science ®Google Scholar
• BanwellBGhezziABar-OrAMikaeloffYTardieuMMultiple sclerosis in children: clinical diagnosis, therapeutic strategies, and future directionsLancet Neurol200761088790217884679
   PubMed Web of Science ®Google Scholar
• EbersGCEnvironmental factors and multiple sclerosisLancet Neurol20087326827718275928
   PubMed Web of Science ®Google Scholar
• KulieTGroffARedmerJHounshellJSchragerSVitamin D: an evidence-based reviewJ Am Board Fam Med200922669870619897699
   PubMed Web of Science ®Google Scholar
• PohlDEpidemiology, immunopathogenesis, and management of pediatric central nervous system inflammatory demyelinating conditionsCurr Opin Neurol200821336637218451724
   PubMed Web of Science ®Google Scholar
• BanwellBKennedyJSadovnickDIncidence of acquired demyelination of the CNS in Canadian childrenNeurology200972323223919153370
   PubMed Web of Science ®Google Scholar
• GhezziADeplanoVFaroniJMultiple sclerosis in childhood: clinical features of 149 casesMult Scler19973143469160345
   PubMed Web of Science ®Google Scholar
• BoikoAVorobeychikGPatyDDevonshireVSadovnickDUniversity of British Columbia MS Clinic NeurologistsEarly onset multiple sclerosis: a longitudinal studyNeurology20025971006101012370453
   PubMed Web of Science ®Google Scholar
• RenouxCVukusicSMikaeloffYNatural history of multiple sclerosis with childhood onsetN Engl J Med2007356252603261317582070
   PubMed Web of Science ®Google Scholar
• ChitnisTGlanzBJaffinSHealyBDemographics of pediatric-onset multiple sclerosis in an MS center population from the Northeastern United StatesMult Scler2009159562763119299440
   PubMed Web of Science ®Google Scholar
• DuquettePMurrayTJPleinesJMultiple sclerosis in childhood: clinical profile in 125 patientsJ Pediatr198711133593633625402
   PubMed Web of Science ®Google Scholar
• SimoneILCarraraDTortorellaCCourse and prognosis in early-onset MS: comparison with adult-onset formsNeurology200259121922192812499484
   PubMed Web of Science ®Google Scholar
• KruppLBBanwellBTenembaumSInternational Pediatric MS Study GroupConsensus definitions proposed for pediatric multiple sclerosis and related disordersNeurology20076816 Suppl 2S7S1217438241
   PubMed Web of Science ®Google Scholar
• TenembaumSChitnisTNessJHahnJSInternational Pediatric MS Study GroupAcute disseminated encephalomyelitisNeurology20076816 Suppl 2S23S3617438235
   PubMed Web of Science ®Google Scholar
• PolmanCHReingoldSCEdanGDiagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald Criteria”Ann Neurol200558684084616283615
   PubMed Web of Science ®Google Scholar
• HahnCDShroffMMBlaserSIBanwellBLMRI criteria for multiple sclerosis: evaluation in a pediatric cohortNeurology200462580680815007138
   PubMed Web of Science ®Google Scholar
• CallenDJShroffMMBransonHMMRI in the diagnosis of pediatric multiple sclerosisNeurology2009721196196719038852
   PubMed Web of Science ®Google Scholar
• CallenDJShroffMMBransonHMRole of MRI in the differentiation of ADEM from MS in childrenNeurology2009721196897319038851
   PubMed Web of Science ®Google Scholar
• YehEAChitnisTKruppLPediatric multiple sclerosisNat Rev Neurol200951162163119826402
   PubMed Web of Science ®Google Scholar
• YehEAWeinstock-GuttmanBLincoffNRetinal nerve fiber thickness in inflammatory demyelinating diseases of childhood onsetMult Scler200915780281019465453
   PubMed Web of Science ®Google Scholar
• NessJMChabasDSadovnickADClinical features of children and adolescents with multiple sclerosisNeurology20076816 Suppl 2S37S4517438237
   PubMed Web of Science ®Google Scholar
• KennedyJO’ConnorPSadovnickADPeraraMYeeIBanwellBAge at onset of multiple sclerosis may be influenced by place of residence during childhood rather than ancestryNeuroepidemiology200626316216716493204
   PubMed Web of Science ®Google Scholar
• GormanMPHealyBCPolgar-TurcsanyiMChitnisTIncreased relapse rate in pediatric-onset compared with adult-onset multiple sclerosisArch Neurol2009661545919139299
   PubMed Web of Science ®Google Scholar
• YehEAWeinstock-GuttmanBRamanathanMMagnetic resonance imaging characteristics of children and adults with paediatric-onset multiple sclerosisBrain2009132Pt 123392340019892770
   PubMed Web of Science ®Google Scholar
• AndersonVSpencer-SmithMLeventerRChildhood brain insult: can age at insult help us predict outcome?Brain2009132Pt 1455619168454
   PubMed Web of Science ®Google Scholar
• Langer-GouldAPopatRAHuangSMClinical and demographic predictors of long-term disability in patients with relapsing-remitting multiple sclerosis: a systematic reviewArch Neurol200663121686169117172607
   PubMedGoogle Scholar
• WaldmanAO’ConnorETennekoonGChildhood multiple sclerosis: a reviewMent Retard Dev Disabil Res Rev200612214715616807911
   PubMedGoogle Scholar
• MacAllisterWSBelmanALMilazzoMCognitive functioning in children and adolescents with multiple sclerosisNeurology20056481422142515851734
   PubMed Web of Science ®Google Scholar
• BanwellBLAndersonPEThe cognitive burden of multiple sclerosis in childrenNeurology200564589189415753431
   PubMed Web of Science ®Google Scholar
• AmatoMPGorettiBGhezziACognitive and psychosocial features of childhood and juvenile MSNeurology200870201891189718474844
   PubMed Web of Science ®Google Scholar
• PohlDWaubantEBanwellBTreatment of pediatric multiple sclerosis and variantsNeurology20076816 Suppl 2S54S6517438239
   PubMed Web of Science ®Google Scholar
• MartinelliVRoccaMAAnnovazziPA short-term randomized MRI study of high-dose oral vs intravenous methylprednisolone in MSNeurology200973221842184819949030
   PubMed Web of Science ®Google Scholar
• TakahashiISawaishiYTakedaOEnokiMTakadaGChildhood multiple sclerosis treated with plasmapheresisPediatr Neurol199717183879308985
   PubMed Web of Science ®Google Scholar
• LehmannHCHartungHPHetzelGRStüveOKieseierBCPlasma exchange in neuroimmunological disorders. Part 1: rationale and treatment of inflammatory central nervous system disordersArch Neurol200663793093516831960
   PubMedGoogle Scholar
• SpaliceAProperziELo FaroVAcamporaBIannettiPIntravenous immunoglobulin and interferon: successful treatment of optic neuritis in pediatric multiple sclerosisJ Child Neurol200419862362615605474
   PubMed Web of Science ®Google Scholar
• DastgirJDiMarioFJAcute tumefactive demyelinating lesions in a pediatric patient with known diagnosis of multiple sclerosis: review of the literature and treatment proposalJ Child Neurol200924443143719189932
   PubMed Web of Science ®Google Scholar
• WaubantEHietpasJStewartTInterferon beta-1a in children with multiple sclerosis is well toleratedNeuropediatrics200132421121311571702
   PubMed Web of Science ®Google Scholar
• MikaeloffYMoreauTDebouverieMInterferon-beta treatment in patients with childhood-onset multiple sclerosisJ Pediatr2001139344344611562627
   PubMed Web of Science ®Google Scholar
• PakdamanHFallahASahraianMAPakdamanRMeysamieATreatment of early onset multiple sclerosis with suboptimal dose of interferon beta-1aNeuropediatrics200637425726017177154
   PubMed Web of Science ®Google Scholar
• GhezziAAmatoMPCapobiancoMTreatment of early-onset multiple sclerosis with intramuscular interferonbeta-1a: long-term resultsNeurol Sci200728312713217603763
   PubMed Web of Science ®Google Scholar
• PohlDRostasyKGärtnerJHanefeldFTreatment of early onset multiple sclerosis with subcutaneous interferon beta-1aNeurology200564588889015753430
   PubMed Web of Science ®Google Scholar
• TenembaumSNSeguraMJInterferon beta-1a treatment in childhood and juvenile-onset multiple sclerosisNeurology200667351151316775230
   PubMed Web of Science ®Google Scholar
• BanwellBRederATKruppLSafety and tolerability of interferon beta-1b in pediatric multiple sclerosisNeurology200666447247616505297
   PubMed Web of Science ®Google Scholar
• KornekBBernertGBalassyCGeldnerJPrayerDFeuchtMGlatiramer acetate treatment in patients with childhood and juvenile onset multiple sclerosisNeuropediatrics200334312012612910434
   PubMed Web of Science ®Google Scholar
• GhezziAAmatoMPAnnovazziPLong-term results of immunomodulatory treatment in children and adolescents with multiple sclerosis: the Italian experienceNeurol Sci200930319319919387545
   PubMed Web of Science ®Google Scholar
• GoodinDSTreatment of multiple sclerosis with human beta interferonInt MS J20051239610816417818
   PubMedGoogle Scholar
• TselisAKhanOLisakRPGlatiramer acetate in the treatment of multiple sclerosisNeuropsychiatr Dis Treat20073225926719300558
   PubMedGoogle Scholar
• CohenBAKhanOJefferyDRIdentifying and treating patients with suboptimal responsesNeurology20046312 Suppl 6S33S4015623669
   PubMed Web of Science ®Google Scholar
• GrayOMMcDonnellGVForbesRBA systematic review of oral methotrexate for multiple sclerosisMult Scler200612450751016900766
   PubMed Web of Science ®Google Scholar
• NeuhausOKieseierBCHartungHPImmunosuppressive agents in multiple sclerosisNeurotherapeutics20074465466017920546
   PubMed Web of Science ®Google Scholar
• CasettaIIulianoGFilippiniGAzathioprine for multiple sclerosis [discussion]J Neurol Neurosurg Psychiatry2009802131219151017
   PubMed Web of Science ®Google Scholar
• MakhaniNGormanMPBransonHMStazzoneLBanwellBLChitnisTCyclophosphamide therapy in pediatric multiple sclerosisNeurology200972242076208219439723
   PubMed Web of Science ®Google Scholar
• Kleinschmidt-DeMastersBKTylerKLProgressive multifocal leukoencephalopathy complicating treatment with natalizumab and interferon beta-1a for multiple sclerosisN Engl J Med2005353436937415947079
   PubMed Web of Science ®Google Scholar
• HuppkePStarkWZürcherCHuppkeBBrückWGärtnerJNatalizumab use in pediatric multiple sclerosisArch Neurol200865121655165819064754
   PubMedGoogle Scholar
• BorrielloGProsperiniLLuchettiAPozzilliCNatalizumab treatment in pediatric multiple sclerosis: a case reportEur J Paediatr Neurol2009131677118406645
   PubMed Web of Science ®Google Scholar
• WiendlHHohlfeldRMultiple sclerosis therapeutics: unexpected outcomes clouding undisputed successesNeurology200972111008101519289741
   PubMed Web of Science ®Google Scholar
• KesselringJNeurorehabilitation in multiple sclerosis – what is the evidence-base?J Neurol2004251Suppl 4IV25IV2915378304
   PubMedGoogle Scholar
• KesselringJBeerSSymptomatic therapy and neurorehabilitation in multiple sclerosisLancet Neurol200541064365216168933
   PubMed Web of Science ®Google Scholar
• ThompsonAJNeurorehabilitation in multiple sclerosis: foundations, facts, and fictionCurr Opin Neurol200518326727115891410
   PubMed Web of Science ®Google Scholar
• GoldmanMDCohenJAFoxRJBethouxFAMultiple sclerosis: treating symptoms, and other general medical issuesCleve Clin J Med200673217718616478042
   PubMed Web of Science ®Google Scholar
• MacAllisterWSBoydJRHollandNJMilazzoMCKruppLBInternational Pediatric MS Study GroupThe psychosocial consequences of pediatric multiple sclerosisNeurology20076816 Suppl 2S66S6917438240
   PubMed Web of Science ®Google Scholar
• Apel-NeuAZettlUKComplementary and alternative medicine in multiple sclerosisJ Neurol2008255Suppl 6828619300965
   PubMed Web of Science ®Google Scholar
• TatarynDJParadigms of health and disease: a framework for classifying and understanding complementary and alternative medicineJ Altern Complement Med20028687789212614539
   PubMed Web of Science ®Google Scholar
• SooIMahJKBarlowKHamiwkaLWirrellEUse of complementary and alternative medical therapies in a pediatric neurology clinicCan J Neurol Sci200532452452816408586
   PubMed Web of Science ®Google Scholar
• HuntleyAA review of the evidence for efficacy of complementary and alternative medicines in MSInt MS J200613151216420779
   PubMedGoogle Scholar
• YadavVBourdetteDComplementary and alternative medicine: is there a role in multiple sclerosis?Curr Neurol Neurosci Rep20066325926716635436
   PubMed Web of Science ®Google Scholar
• Weinstock-GuttmanBBaierMParkYLow fat dietary intervention with omega-3 fatty acid supplementation in multiple sclerosis patientsProstaglandins Leukot Essent Fatty Acids200573539740416099630
   PubMed Web of Science ®Google Scholar
• ZhangSMHernánMAOlekMJSpiegelmanDWillettWCAscherioAIntakes of carotenoids, vitamin C, and vitamin E and MS risk among two large cohorts of womenNeurology2001571758011445631
   PubMed Web of Science ®Google Scholar
• WadeDTMakelaPRobsonPHouseHBatemanCDo cannabis-based medicinal extracts have general or specific effects on symptoms in multiple sclerosis? A double-blind, randomized, placebo-controlled study on 160 patientsMult Scler200410443444115327042
   PubMed Web of Science ®Google Scholar
• MungerKLZhangSMO’ReillyEVitamin D intake and incidence of multiple sclerosisNeurology2004621606514718698
   PubMed Web of Science ®Google Scholar
• VaneyCHeinzel-GutenbrunnerMJobinPEfficacy, safety and tolerability of an orally administered cannabis extract in the treatment of spasticity in patients with multiple sclerosis: a randomized, double-blind, placebo-controlled, crossover studyMult Scler200410441742415327040
   PubMed Web of Science ®Google Scholar
• BradyCMDasGuptaRDaltonCWisemanOJBerkleyKJFowlerCJAn open-label pilot study of cannabis-based extracts for bladder dysfunction in advanced multiple sclerosisMult Scler200410442543315327041
   PubMed Web of Science ®Google Scholar
• ShintoLYadavVMorrisCLapidusJASendersABourdetteDThe perceived benefit and satisfaction from conventional and complementary and alternative medicine (CAM) in people with multiple sclerosisComplement Ther Med200513426427216338197
   PubMed Web of Science ®Google Scholar
• OkenBSKishiyamaSZajdelDRandomized controlled trial of yoga and exercise in multiple sclerosisNeurology200462112058206415184614
   PubMed Web of Science ®Google Scholar
• World Health OrganizationAdherence to Long-term Therapies: Evidence for ActionGenevaWHO2003
   Google Scholar
• LugaresiAAddressing the need for increased adherence to multiple sclerosis therapy: can delivery technology enhance patient motivation?Expert Opin Drug Deliv200969995100219637982
   PubMed Web of Science ®Google Scholar
• KyngasHDuffyMEKrollTConceptual analysis of complianceJ Clin Nurs20009151211022487
   PubMed Web of Science ®Google Scholar
• KlauerTZettlUKCompliance, adherence, and the treatment of multiple sclerosisJ Neurol2008255Suppl 6879219300966
   PubMed Web of Science ®Google Scholar
• RíoJPorcelJTéllezNFactors related with treatment adherence to interferon beta and glatiramer acetate therapy in multiple sclerosisMult Scler200511330630915957512
   PubMed Web of Science ®Google Scholar
• PortaccioEZipoliVSiracusaGSorbiSAmatoMPLong-term adherence to interferon beta therapy in relapsing-remitting multiple sclerosisEur Neurol2008593–413113518057899
   PubMed Web of Science ®Google Scholar
• TreadawayKCutterGSalterAFactors that influence adherence with disease-modifying therapy in MSJ Neurol2009256456857619444532
   PubMed Web of Science ®Google Scholar
• ClericoMBarberoPContessaGFerreroCDurelliLAdherence to interferon-beta treatment and results of therapy switchingJ Neurol Sci20072591–210410817376486
   PubMed Web of Science ®Google Scholar
• CohenBARieckmannPEmerging oral therapies for multiple sclerosisInt J Clin Pract200761111922193017784852
   PubMed Web of Science ®Google Scholar
• FraserCHadjimichaelOVollmerTPredictors of adherence to Copaxone therapy in individuals with relapsing-remitting multiple sclerosisJ Neurosci Nurs200133523123911668881
   PubMedGoogle Scholar
• KyngasHAKrollTDuffyMECompliance in adolescents with chronic diseases: a reviewJ Adolesc Health200026637938810822178
   PubMed Web of Science ®Google Scholar
• KyngasHACompliance of adolescents with asthmaNurs Health Sci19991319520210894643
   PubMedGoogle Scholar
• KyngasHAPredictors of good adherence of adolescents with diabetes (insulin-dependent diabetes mellitus)Chronic Illn200731202818072695
   PubMedGoogle Scholar
• KyngasHCompliance with health regimens of adolescents with epilepsySeizure20009859860411162760
   PubMed Web of Science ®Google Scholar
• KyngasHPredictors of good compliance in adolescents with epilepsySeizure200110854955311792154
   PubMed Web of Science ®Google Scholar
• KyngasHMotivation as a crucial predictor of good compliance in adolescents with rheumatoid arthritisInt J Nurs Pract20028633634112390587
   PubMedGoogle Scholar
• GhezziAImmunomodulatory Treatment of Early Onset MS (ITEMS) GroupImmunomodulatory treatment of early onset multiple sclerosis: results of an Italian Co-operative StudyNeurol Sci200526Suppl 4S183S18616388355
   PubMed Web of Science ®Google Scholar
• TrojanoMPellegriniFPaolicelliDReal-life impact of early interferon beta therapy in relapsing multiple sclerosisAnn Neurol200966451352019847899
   PubMed Web of Science ®Google Scholar
• ComiGMartinelliVRodegherMEffect of glatiramer acetate on conversion to clinically definite multiple sclerosis in patients with clinically isolated syndrome (PreCISe study): a randomised, doubleblind, placebo-controlled trialLancet200937497001503151119815268
   PubMed Web of Science ®Google Scholar
• BanwellBLPediatric multiple sclerosisCurr Neurol Neurosci Rep20044324525215102351
   PubMedGoogle Scholar
• ThannhauserJEMahJKMetzLMAdherence of adolescents to multiple sclerosis disease-modifying therapyPediatr Neurol200941211912319589460
   PubMed Web of Science ®Google Scholar
• SmithBAShuchmanMProblem of nonadherence in chronically ill adolescents: strategies for assessment and interventionCurr Opin Pediatr200517561361816160536
   PubMed Web of Science ®Google Scholar
• RapoffMAManagement of adherence and chronic rheumatic disease in children and adolescentsBest Pract Res Clin Rheumatol200620230131416546058
   PubMed Web of Science ®Google Scholar
• CostelloKKennedyPScanzilloJRecognizing nonadherence in patients with multiple sclerosis and maintaining treatment adherence in the long termMedscape J Med200810922519008986
   PubMedGoogle Scholar
• BrownRTBoevingLaRosaA CarpenterBehavioral and Emotional Disorders in Adolescents: Nature, Assessment, and TreatmentNew YorkGuillford Press2006
   Google Scholar
• Brooks-GunnJDevelopmental Aspects of Health Compliance behaviorHillsdale, NJErlbaum1993
   Google Scholar
• PritchardMTButowPNStevensMMDuleyJAUnderstanding medication adherence in pediatric acute lymphoblastic leukemia: a reviewJ Pediatr Hematol Oncol2006281281682317164651
   PubMed Web of Science ®Google Scholar
• ShawRJPalmerLBlaseyCSarwalMA typology of nonadherence in pediatric renal transplant recipientsPediatr Transplant20037648949314870900
   PubMed Web of Science ®Google Scholar
• EriksonEHIdentity: Youth and CrisisNew YorkW. W. Norton and Company Inc1985
   Google Scholar
• CadmanDBoyleMSzatmariPOffordDRChronic illness, disability, and mental and social well-being: findings of the Ontario Child Health StudyPediatrics19877958058132952939
   PubMed Web of Science ®Google Scholar
• BrownRTMarciasMHandbook of Psychological Services for Children and AdolescentsOxfordOxford University Press2001
   Google Scholar
• RudickRAMillerDMHealth-related quality of life in multiple sclerosis: current evidence, measurement and effects of disease severity and treatmentCNS Drugs2008221082783918788835
   PubMed Web of Science ®Google Scholar
• NortvedtMWRiiseTMyhrKMNylandHIQuality of life in multiple sclerosis: measuring the disease effects more broadlyNeurology19995351098110310496273
   PubMed Web of Science ®Google Scholar
• Benito-LeónJMoralesJMRivera-NavarroJMitchellAA review about the impact of multiple sclerosis on health-related quality of lifeDisabil Rehabil200325231291130314617435
   PubMed Web of Science ®Google Scholar
• BoydJRMacMillanLJExperiences of children and adolescents living with multiple sclerosisJ Neurosci Nurs200537633434216396088
   PubMedGoogle Scholar
• MacAllisterWSChristodoulouCTroxellRFatigue and quality of life in pediatric multiple sclerosisMult Scler200915121502150819965517
   PubMed Web of Science ®Google Scholar
• ThannhauserJEGrief – peer dynamics: understanding experiences with pediatric multiple sclerosisQual Health Res200919676677719357388
   PubMed Web of Science ®Google Scholar
• WalshFFamily resilience: a framework for clinical practiceFam Process200342111812698595
   PubMed Web of Science ®Google Scholar
• RollandJSWalshFFacilitating family resilience with childhood illness and disabilityCurr Opin Pediatr200618552753816969168
   PubMed Web of Science ®Google Scholar
• WarnkeCMeyer Zu HörsteGHartungHPStüveOKieseierBCReview of teriflunomide and its potential in the treatment of multiple sclerosisNeuropsychiatr Dis Treat2009533334019557143
   PubMed Web of Science ®Google Scholar
• RammohanKWShoemakerJEmerging multiple sclerosis oral therapiesNeurology201074Suppl 1S47S5320038763
   PubMed Web of Science ®Google Scholar
• MikaeloffYCaridadeGTardieuMSuissaSKIDSEP study group of the French Neuropediatric SocietyEffectiveness of early beta interferon on the first attack after confirmed multiple sclerosis: a comparative cohort studyEur J Paediatr Neurol200812320520917881262
   PubMed Web of Science ®Google Scholar